Han-lei Wang
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Survival Nomogram for Stage IV (M1a-c) Melanoma: A Population-Based Study Highlighting the Prognostic Correlates of Surgery in Pre-Immunotherapy and Early Immunotherapy Eras.
Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research
Published: July 14, 2026
Association of primary lesion surgery and surgical modality with overall survival in patients with stage IV cutaneous melanoma: a population-based study.
Journal: Translational cancer research
Published: February 08, 2026
The role of PD-L1 in patients with non-small cell lung cancer receiving neoadjuvant immune checkpoint inhibitor plus chemotherapy: a meta-analysis.
Journal: Scientific reports
Published: July 06, 2024
Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 07, 2024
Adjuvant radiotherapy omission in early breast cancer: the PROSPECT trial.
Journal: Lancet (London, England)
Published: December 15, 2023
Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma.
Journal: The Lancet. Oncology
Published: April 06, 2023
Daratumumab, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 20, 2023
Efficacy of immune checkpoint inhibitor as maintenance therapy for advanced or metastatic cancers: A meta-analysis of randomized controlled trials.
Journal: Medicine
Published: October 05, 2022
PD-1/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: July 01, 2022
Efficacy and safety of adjuvant therapy with PD‑1/PD‑L1 inhibitors in cancer.
Journal: Experimental and therapeutic medicine
Published: June 17, 2022
The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis.
Journal: Investigational new drugs
Published: January 12, 2022
Combination therapy with immune checkpoint inhibitors in advanced renal cell carcinoma: A meta-analysis of randomized controlled trials.
Journal: Clinical immunology (Orlando, Fla.)
Published: May 27, 2021
Last Updated: 09/26/2026